These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
556 related items for PubMed ID: 12098849
1. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design. Khanvilkar KH, Huang Y, Moore AD. Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849 [Abstract] [Full Text] [Related]
6. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet. Park C, Lee JH, Jin G, Ngo HV, Park JB, Tran TTD, Tran PHL, Lee BJ. Curr Drug Deliv; 2022 May; 19(5):520-533. PubMed ID: 34420504 [Abstract] [Full Text] [Related]
7. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics. Saravanan M, Sri Nataraj K, Ganesh KS. Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240 [Abstract] [Full Text] [Related]
9. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Lee BJ, Ryu SG, Cui JH. Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604 [Abstract] [Full Text] [Related]
10. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release. Hiremath PS, Saha RN. Drug Deliv; 2008 Apr; 15(3):159-68. PubMed ID: 18379928 [Abstract] [Full Text] [Related]
12. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung KC. J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998 [Abstract] [Full Text] [Related]
13. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling. Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT. Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015 [Abstract] [Full Text] [Related]
14. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. Franek F, Holm P, Larsen F, Steffansen B. Int J Pharm; 2014 Jan 30; 461(1-2):419-26. PubMed ID: 24342711 [Abstract] [Full Text] [Related]
15. Design and study of lamivudine oral controlled release tablets. Ravi PR, Ganga S, Saha RN. AAPS PharmSciTech; 2007 Dec 07; 8(4):E101. PubMed ID: 18181522 [Abstract] [Full Text] [Related]
16. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms. Lu Z, Fassihi R. AAPS PharmSciTech; 2017 Feb 07; 18(2):462-472. PubMed ID: 27106916 [Abstract] [Full Text] [Related]
17. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets. Novak SD, Kuhelj V, Vrečer F, Baumgartner S. Pharm Dev Technol; 2013 Feb 07; 18(2):343-7. PubMed ID: 21916601 [Abstract] [Full Text] [Related]
18. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Ravi PR, Ganga S, Saha RN. Chem Pharm Bull (Tokyo); 2008 Apr 07; 56(4):518-24. PubMed ID: 18379101 [Abstract] [Full Text] [Related]